JP2024545981A5 - - Google Patents
Info
- Publication number
- JP2024545981A5 JP2024545981A5 JP2023574593A JP2023574593A JP2024545981A5 JP 2024545981 A5 JP2024545981 A5 JP 2024545981A5 JP 2023574593 A JP2023574593 A JP 2023574593A JP 2023574593 A JP2023574593 A JP 2023574593A JP 2024545981 A5 JP2024545981 A5 JP 2024545981A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288579P | 2021-12-11 | 2021-12-11 | |
| US63/288,579 | 2021-12-11 | ||
| PCT/US2022/081277 WO2023108126A1 (en) | 2021-12-11 | 2022-12-09 | Compositions and methods for oral administration |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024545981A JP2024545981A (ja) | 2024-12-17 |
| JPWO2023108126A5 JPWO2023108126A5 (https=) | 2026-01-28 |
| JP2024545981A5 true JP2024545981A5 (https=) | 2026-01-28 |
Family
ID=86731317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574593A Pending JP2024545981A (ja) | 2021-12-11 | 2022-12-09 | 経口投与のための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250388638A1 (https=) |
| EP (1) | EP4444352A4 (https=) |
| JP (1) | JP2024545981A (https=) |
| KR (1) | KR20240141165A (https=) |
| CN (1) | CN118613284A (https=) |
| AU (1) | AU2022405604A1 (https=) |
| CA (1) | CA3235948A1 (https=) |
| IL (1) | IL312382A (https=) |
| MX (1) | MX2024007105A (https=) |
| WO (1) | WO2023108126A1 (https=) |
| ZA (1) | ZA202404443B (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| US20070042392A1 (en) * | 2000-02-03 | 2007-02-22 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| KR100944034B1 (ko) * | 2007-04-19 | 2010-02-24 | 한올제약주식회사 | 프로테아제-내성 폴리펩티드의 경구 투여 제형 |
| KR102497242B1 (ko) * | 2016-11-13 | 2023-02-09 | 이매진 파마 | 당뇨병, 고혈압 및 고콜레스테롤혈증을 치료하기 위한 조성물 및 방법 |
| PL3746111T3 (pl) * | 2018-02-02 | 2024-01-15 | Novo Nordisk A/S | Stałe kompozycje zawierające agonistę glp-1 i sól kwasu n-(8-(2- hydroksybenzoilo)amino kaprylowego i substancję poślizgową |
-
2022
- 2022-12-09 IL IL312382A patent/IL312382A/en unknown
- 2022-12-09 CN CN202280074852.8A patent/CN118613284A/zh active Pending
- 2022-12-09 US US18/683,324 patent/US20250388638A1/en active Pending
- 2022-12-09 MX MX2024007105A patent/MX2024007105A/es unknown
- 2022-12-09 AU AU2022405604A patent/AU2022405604A1/en active Pending
- 2022-12-09 JP JP2023574593A patent/JP2024545981A/ja active Pending
- 2022-12-09 WO PCT/US2022/081277 patent/WO2023108126A1/en not_active Ceased
- 2022-12-09 EP EP22905413.5A patent/EP4444352A4/en active Pending
- 2022-12-09 CA CA3235948A patent/CA3235948A1/en active Pending
-
2023
- 2023-03-14 KR KR1020247023226A patent/KR20240141165A/ko active Pending
-
2024
- 2024-06-07 ZA ZA2024/04443A patent/ZA202404443B/en unknown